The data we show suggests that this reconstitution of E-cadherin is part of a mesenchymal-epithelial transition, and therefore represents a potential target for inhibiting the metastatic potential of colorectal tumours, reinforced by the ability of cyclopamine to reduce tumour cell invasion in an in vitro model. Here, CDH1 is linked to colorectal neoplasm.